Table 3 Baseline characteristics of patients without SVR
| Â | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 |
|---|---|---|---|---|---|
Type of non-SVR | Relapse | Relapse | Nonresponse | Nonresponse | Nonresponse |
Ribavirin usage | No | No | No | No | No |
Prior treatment | No | No | No | No | No |
Gender | Male | Female | Female | Female | Female |
Age, years | 59 | 57 | 36 | 62 | 40 |
BMI, kg/m2 | 28.3 | 19.5 | 20.9 | 21.6 | 33.4 |
DM | Yes | No | No | No | No |
HBV coinfection | No | No | No | No | No |
Prior HCC | No | No | No | No | No |
Cirrhosis | No | No | No | No | No |
Fib-4 score | 0.86 | 1.45 | 0.67 | 1.48 | 1.09 |
Genotype | 2 | 2 | 1b | 1b | 2 |
HCV RNA, IU/ml | 17 | 8,339,147 | 22,047 | 1,293,629 | 335,076 |
AST, U/L | 21 | 28 | 21 | 20 | 70 |
ALT, U/L | 29 | 22 | 22 | 14 | 124 |
Total bilirubin, mg/dl | 0.4 | 0.5 | 0.6 | 0.9 | 0.4 |
Direct bilirubin, mg/dl | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 |
Creatinine, mg/dl | 1.18 | 0.83 | 0.57 | 0.91 | 0.53 |
eGFR, ml/min/1.73Â m2 | 67.15 | 75.31 | 127.56 | 66.58 | 135.8 |
Albumin, g/dl | 4.4 | 4.8 | 4 | 4.3 | 4.5 |
WBC, 109 cells/L | 8.8 | 6.5 | 5.2 | 4.9 | 5.3 |
Hemoglobin, g/dl | 13.5 | 13.8 | 12.5 | 12.9 | 13.1 |
Platelet, 109 cells/L | 269 | 234 | 241 | 224 | 230 |
INR | 1.02 | 0.98 | 1.02 | 1.02 | 1.06 |